Study on Cannabidiol for Reducing Anxiety and PTSD Symptoms in Dutch Uniformed Personnel

2 1

What is this study about?

This clinical trial is focused on studying the effects of a treatment for individuals experiencing symptoms of anxiety disorders and Post-Traumatic Stress Disorder (PTSD). The treatment being tested is a substance called Cannabidiol (CBD), which is a chemical compound found in cannabis plants. In this study, CBD is administered in the form of capsules. The purpose of the study is to explore how a two-week course of CBD might help reduce anxiety symptoms before starting therapy for anxiety or PTSD.

The study involves participants who are Dutch uniformed personnel, such as police officers, firefighters, ambulance paramedics, military personnel, or veterans. Participants will take CBD capsules daily for two weeks. During this period, researchers will monitor changes in anxiety levels using a tool called Beck’s anxiety index. Additionally, the study will assess how CBD affects fear responses, stress regulation, and sleep quality. These assessments will involve questionnaires, physiological measurements, and a sleep watch to gather comprehensive data on the effects of CBD.

By examining these factors, the study aims to provide insights into whether CBD can be beneficial in managing anxiety symptoms and improving overall well-being before starting traditional therapy for anxiety or PTSD. The findings could potentially lead to new approaches in preparing individuals for therapy, enhancing their treatment outcomes.

1 joining the study

Upon joining the study, you will be informed about the purpose and procedures of the trial. You will be asked to provide consent to participate.

You will be assessed to ensure you meet the criteria for participation, which includes being a member of the Dutch uniformed personnel, aged between 18-65, and waiting for therapy for trauma or anxiety-related disorders.

2 initial assessment

An initial assessment will be conducted to evaluate your anxiety levels using Beck’s anxiety index. This will help establish a baseline for your anxiety symptoms.

3 medication administration

You will begin a 2-week course of cannabidiol (CBD) treatment. The medication will be provided in the form of capsules, taken orally.

The dosage and frequency of the CBD capsules will be explained to you by the study team. It is important to follow the instructions carefully for the duration of the 2-week period.

4 weekly assessments

During the 2-week period, your anxiety levels will be monitored weekly using Beck’s anxiety index to observe any changes.

Additional assessments will be conducted to evaluate the effects of CBD on fear responses, stress regulation, and sleep quality. These may include questionnaires, physiological measurements, and the use of a sleep watch.

5 completion of trial

At the end of the 2-week period, a final assessment will be conducted to evaluate the overall effects of the CBD treatment on your anxiety symptoms.

You will be provided with information on the next steps and any follow-up that may be required.

Who Can Join the Study?

  • Must be a member of the Dutch uniformed personnel, such as (former) police officers, firefighters, ambulance paramedics, military personnel, or veterans.
  • Must be between the ages of 18 and 65.
  • Must be waiting for therapy to treat a trauma and stressor-related disorder or an anxiety disorder. This is determined by a psychiatric interview called the MINI PLUS.

Who Cannot Join the Study?

  • People with certain psychological disorders such as PTSD (Post-Traumatic Stress Disorder) or anxiety disorders cannot participate.
  • Individuals who are not within the specified age range for the study.
  • Participants who do not belong to the specified clinical trial groups.
  • Individuals who are considered part of a vulnerable population, which means they might need special protection or care, are not eligible.

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

No sites found in this category

Other Sites

Site Name City Country Status
Universitair Medisch Centrum Utrecht Utrecht The Netherlands

Want to learn more about this study or check if you can participate? Contact us.

Trial status

Country Status Recruitment Start
The Netherlands The Netherlands
Not recruiting
01.07.2024

Trial locations

Investigated drugs:

Cannabidiol (CBD) is a natural compound found in the cannabis plant. It is often used for its potential calming effects and is being studied for its ability to help reduce anxiety symptoms. In this clinical trial, CBD is being given to participants for two weeks to see if it can help ease anxiety symptoms before they start other treatments for anxiety or PTSD. The goal is to see if CBD can make these symptoms more manageable for people who work in high-stress jobs, like those in uniformed services in the Netherlands.

Post-Traumatic Stress Disorder (PTSD) – PTSD is a psychological disorder that can develop after experiencing or witnessing a traumatic event. It is characterized by persistent and intrusive memories of the trauma, which can lead to severe emotional distress. Individuals with PTSD may experience flashbacks, nightmares, and severe anxiety. They often avoid situations or stimuli that remind them of the traumatic event. Over time, PTSD can lead to changes in mood and cognition, including feelings of detachment and negative thoughts about oneself or the world. The disorder can also cause heightened arousal responses, such as being easily startled or having difficulty sleeping.

Anxiety Disorders – Anxiety disorders encompass a range of mental health conditions characterized by excessive fear or worry. These disorders can manifest as generalized anxiety disorder, panic disorder, social anxiety disorder, and specific phobias, among others. Individuals with anxiety disorders often experience intense, prolonged feelings of nervousness or dread. Physical symptoms may include increased heart rate, sweating, trembling, and fatigue. Anxiety disorders can interfere with daily activities and relationships, as the fear or worry can be overwhelming and difficult to control. The progression of these disorders varies, with symptoms potentially fluctuating in intensity over time.

Trial ID:
2024-514783-78-00
Protocol code:
20U-0014
Trial Phase:
Therapeutic exploratory (Phase II)

Other Trials to Consider

  • Title: Study of Hydrocortisone Treatment to Improve Fear Response in Adults with Post-Traumatic Stress Disorder (PTSD) and Hormonal System Changes

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Personalized Dosing of Sertraline, Aripiprazole, and Risperidone for Patients with Mood, Anxiety, or Psychotic Disorders

    Recruiting

    3 1 1 1
    Investigated diseases:
    Germany The Netherlands Spain